86 related articles for article (PubMed ID: 19589798)
1. Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention.
de la Hera JM; Delgado E; Hernández E; García-Ruiz JM; Vegas JM; Avanzas P; Lozano I; Barriales-Villa R; Hevia S; Martín JS; Alvarez F; Morís C
Eur Heart J; 2009 Nov; 30(21):2614-21. PubMed ID: 19589798
[TBL] [Abstract][Full Text] [Related]
2. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Lenzen M; Ryden L; Ohrvik J; Bartnik M; Malmberg K; Scholte Op Reimer W; Simoons ML;
Eur Heart J; 2006 Dec; 27(24):2969-74. PubMed ID: 17090612
[TBL] [Abstract][Full Text] [Related]
3. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF;
Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207
[TBL] [Abstract][Full Text] [Related]
4. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
[TBL] [Abstract][Full Text] [Related]
5. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients.
Charfen MA; Ipp E; Kaji AH; Saleh T; Qazi MF; Lewis RJ
Acad Emerg Med; 2009 May; 16(5):394-402. PubMed ID: 19302369
[TBL] [Abstract][Full Text] [Related]
6. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
[TBL] [Abstract][Full Text] [Related]
7. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
[TBL] [Abstract][Full Text] [Related]
8. The influence of diabetes mellitus on the practice and outcomes of percutaneous coronary intervention in the community: a report from the HCA database.
Kugelmass AD; Cohen DJ; Houser F; Mack M; Simon AW; Battaglia SL; Tarkington LG; Becker ER; Culler SD
J Invasive Cardiol; 2003 Oct; 15(10):568-74. PubMed ID: 14519889
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
[TBL] [Abstract][Full Text] [Related]
11. PCI versus CABG for multivessel coronary disease in diabetics.
Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
[TBL] [Abstract][Full Text] [Related]
12. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
[TBL] [Abstract][Full Text] [Related]
13. Analysis of recurrent revascularization events following percutaneous coronary intervention of diabetic patients.
Anselmino M; Delcrè S; Moretti C; Biondi-Zoccai G; Omedè P; Sciuto F; Trevi GP; Sheiban I
Minerva Cardioangiol; 2009 Apr; 57(2):151-7. PubMed ID: 19274025
[TBL] [Abstract][Full Text] [Related]
14. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of glucose metabolism profile in coronary disease. Prospective study in hospitalized patients.
Candeias R; Cacodecar S; Gomes V
Rev Port Cardiol; 2005 May; 24(5):703-11. PubMed ID: 16041966
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of patients with diabetes mellitus and chronic total occlusion treated with drug-eluting stents.
De Felice F; Fiorilli R; Parma A; Nazzaro MS; Dibra A; Musto C; De Santis A; Violini R
J Invasive Cardiol; 2008 Dec; 20(12):651-4. PubMed ID: 19057029
[TBL] [Abstract][Full Text] [Related]
18. Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart.
Anselmino M; Ohrvik J; Malmberg K; Standl E; Rydén L;
Eur Heart J; 2008 Jan; 29(2):177-84. PubMed ID: 18156611
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease.
Briguori C; Colombo A; Airoldi F; Focaccio A; Iakovou I; Chieffo A; Michev I; Montorfano M; Bonizzoni E; Ricciardelli B; Condorelli G
Am Heart J; 2005 Oct; 150(4):807-13. PubMed ID: 16209986
[TBL] [Abstract][Full Text] [Related]
20. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.
Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R
Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
